Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
Phase 2
Recruiting
- Conditions
- Hematological Malignancy
- Interventions
- Drug: CAR-T cell therapy
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Shanxi Bethune Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06238336
- Locations
- 🇨🇳
ShanxiBethuneH, Taiyuan, Shanxi, China
Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione
Not Applicable
Completed
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Behavioral: routine health educationBehavioral: psychological nursingBehavioral: MBSR therapyBehavioral: exercise therapy
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Shanxi Bethune Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06224504
- Locations
- 🇨🇳
Combined Mindfulness-Based Stress Reduction and Exercise Intervention for Improving Psychological Well-being in Chinese Patients with Non-Small Cell Lung Cancer, Taiyuan, Shanxi, China
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Phase 3
Recruiting
- Conditions
- Relapsed or Refractory Acute Myeloid Leukemia
- Interventions
- Drug: Granulocyte Colony-Stimulating Factor
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Shanxi Bethune Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05726110
- Locations
- 🇨🇳
Tao Wang, Taiyuan, Shanxi, China
© Copyright 2025. All Rights Reserved by MedPath